scores over its analogue, S, in existing as an anion (selenolate) at biological pH (acid dissociation constant: selenocysteine 5.2, cysteine 8.5). This property enables it to carry out biological redox reactions [22, 24] and is the reason of its presence in the catalytic sites of redox enzymes like glutathione peroxidase, thioredoxin reductase and formate dehydrogenase.
Effects of selenium deficiency in humans
It has been widely accepted that selenium deficiency may not cause illness by itself. The only two pathologies for which Se has been actually identified as the only cause are the Kaschin-Beck and the Keshan diseases which occur only in rural areas of China and Russia, mainly eastern Siberia, characterized by food systems with exceedingly low selenium amounts [25] . On the other hand it has been proved the role of selenium deficiency in the occurrence of several human diseases [26, 27] . In this section a summary of the pathological states correlated to selenium deficiency will be described.
Kaschin-Beck disease:
Kaschin-Beck disease is a chondrodystrophy affecting the epiphyseal and articular cartilage and the epiphyseal growth plates of growing bones. It is characterized by enlarged joints, shortened fingers, toes and extremities and, in severe cases, dwarfism [28, 11] . It is still not clear if selenium deficiency is the primary cause of Kaschin-Beck disease; it is more likely that an endemic Se deficiency is a pre-disposing factor to the pathogenic effects of some other agents [11] .
Keshan disease: Keshan disease is a multifocal myocarditis occurring primarily in children aged 2-10 years and, to a lesser extent, in women of child-bearing age [29, 30] . Its main manifestations are insufficiencies of cardiac function, cardiac enlargement, arrhythmias, and electrocardiographic and radiographic abnormalities. It was first described in China more than 100 years ago and in 1935, the involvement of selenium deficiency in its etiology was proved [28] .
However, selenium is of little or no therapeutic value after the occurrence of the pathology. It has been suggested that Keshan disease may be caused by RNA-viruses, whose pathogenicity may be increased by severe deficiencies of Se and other antioxidant compounds [31, 32] .
Ageing: Ageing is defined as the lifelong accumulation of molecular damage to cells and tissues in response to exposure to stress associated with lifestyle. Such damage results in loss of functions and an increased vulnerability to diseases, ultimately leading to death. Nutrition and lifestyle are key environmental factors that can modify the rate of damage accumulation in cells [33] . Trace elements, and especially Se, may act on the ageing process mainly through the modulation of oxidative damage and DNA repair capacity. The ability of Se to attenuate oxidative damage or enhance repair capacity depends on its action as essential amino acid (SeCys) for anti-oxidant enzymes such as the different types of glutathione peroxidases. It has been hypothesized that GPx which scavenges H 2 O 2 and prevents the initiation of free radical chain reactions, may extend life span and prevent age-related functional disorders [34] . The enhanced repair capacity induced by Se was proved in human leukocytes, where bleomycin-induced DNA damages are repaired more efficiently in presence of Se in the form of selenomethionine (SeMet) [35] . Similarly it was proved that SeMet could also induce a DNA repair response in normal human fibroblasts in vitro, protecting cells from DNA damage [36] . Trace elements, among which Se, have the capacity to modulate the rate at which damage is accumulating over time. In this context Se has the potential to influence the prevalence of chronic disease thanks to its implication in the healthy immune response, the regulation of inflammatory pathways, the protection against some forms of cancer and the reduction of cardiovascular disease-related mortality [37] . Several papers deal with an increased mortality and prevalence of chronic diseases correlated with low Se intake. Additionally, as for many other micronutrients, Se inadequacy is common in elder people and it was proved that Se status declines in an age-dependent manner [38] .
Viral infections:
Selenium deficiency can have a deep impact on the genome of RNA viruses; in particular it may contribute to the emergence of new viral strains capable of promoting epidemics [39] . It was described a non-virulent Coxsackie virus that, when passing through a Se-deficient host, may acquire more virulent features leading to cardiac damages to the host [31] . The enhanced virulence depends on modifications to the nucleotide sequence resulting in phenotypical changes [40] that were maintained also after subsequent passages through animals with normal selenium status [41] . It was also proved a correlation between Se deficiency and a decreased survival in HIV-infected patients [42] : Se-deficient HIV-infected patients are 19,9 times more likely to die from HIV-related causes than those with adequate Se levels [43] . This may depend on a protective role that Se displays against HIV infections: it is, in fact, a strong inhibitor of HIV replication in vitro [44] .
Thyroid function:
The thyroid has the highest selenium concentration of all tissues [45] : its importance in this gland is suggested by the fact that the deiodinases (Type I, II and III) are all Se-enzymes [46] . In particular the seleniumdependent iodothyronine deiodinases produce the active thyroid hormone, triiodothyronine T3, from its inactive precursor, thyroxine T4. It was demonstrated that a relatively mild selenium depletion (<0.9 μmol/l ), in both infants and elderly subjects, may induce changes in the ratio T3/T4 [47] . Furthermore selenium, in the form of GPx3, protects thyroid cells from the hydrogen peroxide, avoiding its use by thyroid peroxidase to produce triiodothyronine or thyroxine [45] . Selenium also displayed to positively affect the autoimmune hyperthyroidism, known as Graves" disease [48] .
Heart disease: The benefits induced by selenium on the cardiovascular system depend on the ability of selenoproteins to prevent oxidative modifications of lipids, inhibit platelet aggregation and reduce inflammation [42] . Se-deficiency is correlated with an increased production of radical oxygen species that may lead to the oxidation of low density lipoprotein (LDL), giving rise to the beginning of atherogenesis in heart diseases [49] . However, in epidemiological studies, clear evidences are still missing between low Se status and an increased risk of heart diseases [50] . Early supportive evidences in the USA suggested that a higher mortality of heart diseases was linked to Se-deficient areas [51] ; on the contrary epidemiological studies from other countries, namely Finland, a country of low Se status, gave contradictory results [52] .
Cancer: Epidemiological studies showed an inverse association between blood Se concentration and the risk of several cancers, primarily in men [53] . Prospective studies have provided some evidence for a beneficial effect of selenium on the risk of lung, bladder, colorectal, liver, esophageal, thyroid and prostate cancers [54] . Generally, it is recognized that selenium may be considered as an anticarcinogenic agent [55] whose effects depend on its chemical form and dosage.
Several metabolite pools seem to be of particular importance, such as selenite, selenodiglutathione, methylselenol, selenomethionine and Se-methylselenocysteine [56] , whose molecular action deals with alterations in the metabolism of endo-or exogenous carcinogens [57] . However, the exact mechanisms of the anticarcinogenic effect of Se remain still unclear.
Fixation strategies of selenium into living organisms
Inorganic forms of Se, namely selenate and selenite, can be efficiently reduced in living organisms and then incorporated into proteins. Se-containing proteins can be divided into three main groups according to their mechanisms of insertion/interaction of Se: i) post-translational binding as a cofactor; ii) non-specific incorporation (SeMet: selenomethionine); iii) specifically incorporated during translation as SeCys (selenocysteine) [58] . As just mentioned, only two selenium-amino acids are known to be present into proteins: SeMet and SeCys. This incorporation occurs because of the strong relationship between Se and S. So, what happens in mammals, but also in prokaryotes, is that methionine (Met) and SeMet are treated in the same way. This is due to the fact that in nature there is no evidence of the presence of a specific tRNA SeMet in any organism. This means that the incorporation of SeMet into proteins is an unselective event in which a substitution of Met for SeMet happens in tRNA Met [59] . In mammals SeMet can substitute Met in the total body protein pool in a manner that is dependent on the nutritional supplied selenomethionine.
Unlike SeMet, the incorporation of SeCys is a co-translational specific event that employs a complex machinery of proteins and is genetically encoded; indeed the incorporation of free SeCys could not occur since the abundance of cysteine in the cell inhibits this phenomenon avoiding an improper loading of SeCys onto tRNA Cys [60] . SeCys is therefore described as the 21 st amino acid identified as the major biological form of Se present in enzymes and proteins belonging to bacteria, archaea and eukaryotes [61] . The insertion mechanism of SeCys presents several common aspects among the different living kingdoms. SeCys is always encoded by an in-frame triplet TGA (in DNA) or UGA (in mRNA), that normally functions as a stop codon, but that is recognized as the specific codon for SeCys if a series of other conditions occurs. The first one is the presence of a secondary mRNA structure characterized by a stem-loop, called SECIS (SelenoCysteine Insertion Sequence) element. This secondary structure necessary for decoding UGA codon differs among phyla in consensus sequence, position in the gene and shape. The first SECIS element was identified in bacteria (Escherichia coli) immediately downstream of the UGA [62] , while in eukarya it is present in the 3" UTR region and its elimination completely inhibits selenoproteins synthesis [63, 64] . The identification of conserved features in bacterial SECIS is very difficult; moreover putative SECIS elements identified in several bacterial species seem to have no similarity to each other or to the E. coli one [65] . Furthermore there is no certainty of the presence of SECIS elements in all bacterial selenoprotein genes.
Another necessary condition is the presence of a specific tRNA called tRNA SerSec . This particular tRNA differs for sequence between eubacteria and eukarya, but in both cases it is not charged with SeCys but with serine by a seryltRNA synthetase [66, 67, 68] . The conversion of seryl-tRNA SerSec into selenocysteyl-tRNA is then achieved by a selenocysteine synthase that employs selenophosphate, the "activated form" of Se, as selenium donor. In bacteria selenocysteine synthase is a 500 kDa protein [69] . In mammals another step is necessary for the transformation of seryltRNA SerSec to selenocysteyl-tRNA SerSec : a specific phosphorylation at the serine -OH group [70] . tRNA SerSec performs other tasks: it must recognize specific translation factors, SelB in bacteria and SBP-2 and mSelB in eukarya, avoiding the recognition of canonical elongation factors.
Finally a correct translation requires the specific recognition of SECIS by SelB in bacteria and SBP-2 and mSelB in eukarya. Bacterial SelB possesses several binding sites: for the tRNA SerSec , the SECIS element, GTP and the ribosome.
This protein has a N-terminal region homologous to EF-Tu that is normally responsible for protein synthesis; while its C-terminus is able to bind the SECIS element [71, 72] . SelB is specifically able to bind selenocysteyl-tRNA SerSec , while it does not recognize the seryl-form. This characteristic binding induces the enhancement of its affinity with SECIS. In eukaryotic cells this function is performed by two distinct proteins: SBP-2 and mSelB. SBP-2 shows no homology to bacterial SelB and does not specifically recognize tRNA SerSec [73] , while mSelB is an elongation factor that specifically binds tRNA SerSec and that shows homology to the bacterial counterpart.
To summarize (Figure 1 ), four gene products are involved in SeCys biosynthesis and insertion in bacteria: SelA (selenocysteine synthase), SelB (a special translation factor that recognizes selenocystyl-tRNA SerSec ), SelC (SeCysspecific tRNA) and SelD (selenophosphate synthase) [74] . In eukarya, this process is comparable even if with some differences already described and so any model is still speculative. Even if selenoproteins are present in all the three domains of life (bacteria, eukarya and archaea), some organisms, such as yeasts and higher plants, does not use SeCys and seem to have lost the SeCys insertion machinery during evolution [75] .
For what concerns plants, Se is not an essential element even if some beneficial effects on plants growth have already been demonstrated [76] . Plants can be divided into Se non-accumulators and Se hyperaccumulators: the first are able to discriminate against selenate to take up sulfate, the latter preferentially absorb Se over sulfur [77] . This can suggest that, in non accumulator plants, selenate is taken up by the same transporters as sulfate, while hyperaccumulators could express additional specific transporters. Though no selenoprotein exists in plants, SeCys is a fundamental intermediate used by plants to produce other seleno-amino acids and also volatile Se-metabolites. Plants are able to take up from the soil both selenate and selenite [78] . Selenate can be easily reduced to selenide; two different pathways are possible: i)
via non-enzymatic reactions and glutathione reductase; ii) via APS (adenosine 5"-phosphosulfate) reductase and sulfite reductase [79] . Then selenide can be converted to SeCys that can follow two pathways: in the first one, it can enter the Met pathway in order to synthesize SeMet via selenocystathionine and selenohomocysteine [80] . The second possibility consists in the methylation of Cys with the formation of methylselenocysteine (MeSeCys) used for the biosynthesis of γ-glutamylmethylselenocysteine [81] .
Selenoproteins: roles and metabolism
Once ingested with the diet, SeMet and other organic Se-compounds can be non-specifically incorporated into human proteins such as albumin or hemoglobin in substitution of Met. SeMet can also be trans-selenated to SeCys. It must be underlined that SeCys ingested with the diet or derived from SeMet cannot be used in its original form to synthesize human selenoproteins in our bodies. SeCys has to be prior converted into H 2 Se (hydrogen selenide) by the action of a β-lyase and then phosphorylated to selenophosphate by a selenophosphate synthetase [7] . Selenophosphate will then follow the pathway already described in the previous paragraph.
Se-containing proteins formed in this way constitute the human selenoproteome that includes 25 proteins comprising five glutathione peroxidase (GPx), three iodothyronine deiodinase (DIO), three thioredoxin reductase (TRxR), selenoprotein SelP and other proteins listed in Table 1 Human selenoproteins possess several functions ranging from protection against oxidative stress, to Se storage and transport, from SeCys synthesis to redox signaling [75, 82] .
The evolutionary advantage related to the use of selenoproteins resides in the high performance of SeCys in catalysis [83] : the Se atom confers different properties rendering SeCys a stronger nucleophile than the less reactive Cys. For this reason selenoproteins can have a higher reaction rate with electrophilic substrates [84] .
Glutathione peroxidase 1 (GPx1) was the first selenoprotein to be identified in humans [85] , and, subsequently, the GPx family became one of the best characterized groups of selenoproteins. Today this family includes five isoenzymes in humans [58] . GPx family possesses a wide spectrum of antioxidant protection that depends on dietary Se levels, thanks to the variability in the physiological localization and substrate specificity of each member [86] . Apparently all of them share the catalytic mechanism of the GPx1 enzyme and the factors controlling or modulating their activity are not known with certainty, even if all of them seem to share the same catalytic mechanism involving three conserved amino acids: selenocysteine, tryptophan (Trp157) and glutamine (Gln83) [87] . A mechanism of action has been proposed by Prabhakar and coworkers [88] and is described in figure 2 . In the first step, hydrogen peroxide reduction is coupled with the oxidation of the selenolate anion (or selenol) to the selenenic acid. During the second reaction, the selenenic acid reacts with the substrate GSH to produce the selenosulfide adduct (E-Se-SG). In the third step, a second molecule of GSH attacks the seleno-sulfide adduct originating the disulfide GS-SG and regenerating the active form of the enzyme.
GPx1 is one of the most abundant and ubiquitously expressed selenoproteins; it is a homotetrameric cytosolic enzyme very abundant in liver [58, 89, 90] . It is the most sensitive to changes in Se status: low Se concentrations can cause a decrease in its mRNA and protein levels [91] . GPx2 is principally present in the gastrointestinal tract, even if it is also detectable in liver [92] ; its main role is to protect intestinal epithelium from oxidative stress. Another important member of this family is GPx3 that is the only one to be secreted constituting about 20% of the total Se in the plasma [93] , even though this number may change depending on Se status [94] ; for this reason it is considered a bioindicator of Se status correlated with nutrition. Disorders linked to this family of selenoproteins are cardiovascular diseases, cancer and epilepsy [95, 96, 97] .
Figure 2:
Simplified catalytic mechanism of the glutathione peroxidase: in the first step, SeCys is oxidixed by hydrogen peroxide to form a selenenic acid, which is then reduced again by glutathione.
Another important selenoprotein family is represented by thioredoxin reductase that use NADPH to catalyze the reduction of oxidized thioredoxin. TrxR belongs to a family of homodimeric pyridine nucleotide disulfide reductase [58] . In humans are known three TrxR: TrxR1 is present at cytoplasmic/nuclear level, TrxR2 is a mitochondrial protein with highest levels in the prostate, liver and small intestine, while TrxR3 is a thioredoxin-glutathione reductase testesspecific. TrxR1 and 2 are distributed in several tissues [98] . It has been reported that TrxR system is overexpressed in several tumors and cancer cell lines [99] .
Also the deiodinase family consists of three isoforms: DIO1, DIO2 and DIO3. They are all membrane-bound enzymes sharing sequence homology and catalytic properties [100] . All three members are expressed in a number of fetal and adult tissues, where they may control the concentration of active thyroid hormone available to specific tissues or cell types at certain stages of development [101] . Disorders in this protein family are also correlated to Kaschin-Beck disease and may clearly lead to thyroid dysfunction, since the correct functionality of this gland depends on two trace elements, iodine and selenium, that are commonly low in Western diets. [102, 103] .
A peculiar member of the human selenoproteome is selenoprotein P. SelP is unique since is the only member of the selenoprotein family containing multiple SeCys residues in its sequence per protein molecule. In humans it contains 10
SeCys residues. This is exactly the feature that suggests a role in selenium transport [97] . SelP represents the major selenoprotein in plasma, also providing more than 50% of the total plasma selenium [104] . Se derived from the diet is transported to the liver and used for SelP synthesis. SelP is then secreted into the plasma and delivered to target tissues where it enters the cells via a receptor-mediated mechanism. Within the cell, the degradation of SelP and of its 10
SeCys liberates free Se that can be subsequently employed for the synthesis of novel selenoproteins [105] . In conclusion, the bioavailability of Se for humans is not only related to the adequate amount ingested with the diet, but strongly depends on the correct action of SelP. Several studies have reported that SelP displays additional functions as highlighted by the presence of different domains having glutathione peroxidase activity, heparin and heavy metal ion binding capacity [106] . For example the first SeCys present at the N-terminus has been suggested to supply antioxidant capacity to cells [107] . SelP has been linked to several human diseases: in Alzheimer"s disease, a co-localization of
SelP with amyloid plaques was demonstrated [107] . This observation coupled with lower circulating SelP during inflammatory conditions like sepsis and Crohn"s disease [108, 109] may have important implications for potential links between Se status, inflammation and neurological disorders.
The study of SeCys incorporation into bacterial selenoproteins is very complex and the knowledge of the evolution of Se utilization traits is still poor. In a study by Zhang and coworkers [110] , 25 known bacterial selenoprotein families, comprising 285 selenoprotein sequences, were analyzed. The results indicated that FdhA (formate dehydrogenase) and SelD (selenophosphate synthetase) were the most widespread Se-proteins, indeed, at least one of these two proteins was present in each selenoprotein-containing microorganism. Moreover, in most selenoprotein families, SeCys-containing proteins are less represented than the corresponding Cys-containing homologs, suggesting a close evolutionary relationship between these proteins, even if, nowadays, is still not clear whether SeCys evolved from Cys or viceversa.
In the same study, Deltaproteobacteria, Firmicutes/Clostridia and Actinobacteria resulted to be the three phyla containing the highest number of selenoprotein families: 22, 16 and 12 respectively. A common feature of the selenoprotein-rich organisms belonging to these three phyla is that they are mainly anaerobic or hyperthermophiles.
The first bacterial selenoproteins were described and analyzed in E. coli. These proteins are three molybdoselenoprotein formate dehydrogenase: FdhH (associated with hydrogen production), FdhN (induced in the presence of nitrate) and FdhO (also detected during aerobic growth) [111] . They are all membrane-associated; FdhN and FdhO are highly related at both the amino acid sequence and functional levels. SeCys role is fundamental: it coordinates
Molybden present in the pterin cofactor participating in the catalysis [112] . As already described, the formate dehydrogenase family is highly represented, being present in 24 different bacterial species [113] . In many of these microorganisms, Fdh was the only selenoprotein and its gene often flanked genes involved in SeCys insertion. Fdh catalyzes the oxidation of formate to CO 2 and is involved in energy metabolism.
Many other selenoproteins are present in bacteria; an example is the glycine reductase (GR) system. It is present mainly in clostridia where it catalyzes the reductive deamination of glycine to acetylphosphate and ammonia [114] . This system has been studied in two anaerobic Gram positive bacteria, Clostridium sticklandii and Eubacterium acidaminophilum and in the Gram negative Treponema denticola [115] . The GR system is composed by three proteins called protein A, B and C [116] . Protein A is a 17-kDa protein containing a SeCys and encoded by grdA [117] ; protein B derives from grdB encoding a 47-kDa SeCys-containing protein [118] and grdE which encodes a pro-protein of 48 kDa that will be posttranslationally processed into two proteins of 25 and 22 kDa respectively [119] . Last, protein C is encoded by grdC (54 kDa) and grdD (40 kDa) [120] . Interestingly in most organisms, the genes involved in GR system form an operon that includes genes of the thioredoxin system. Another selenoprotein involved in this complex system is formate dehydrogenase, indeed formate represses the oxidation of glycine in favor of GR [121] .
In strictly anaerobic bacteria several enzymes involved in antioxidant defense are present. Methionine sulfoxide reductase (Msr), as an example, reduces oxidized Met present in proteins. MrsA acts specifically on S-form of methionine sulfoxide, while MrsB on the R-form [122] . Interestingly both MsrA and MsrB can be or not selenoproteins, depending on the microorganism [123] .
Selenophosphate synthetase (SPS) is a SeCys-containing protein identified in several bacterial species both Gram positive and negative. In E. acidaminophilum SPS was experimentally shown to possess a SeCys residue, even if the exact role of SeCys during the catalysis (synthesis of selenophosphate) is still not clear [124] .
In a recent paper [125] , the ability of a Lactobacillus reuteri strain, a probiotic lactic acid bacterium, to synthesize
SeCys-containing proteins was demonstrated. The authors proved the selective insertion of SeCys residues within specific proteins (glyceraldehyde 3-phosphate dehydrogenase, pyruvate kinase, phosphoketolase, 6-phosphogluconate dehydrogenase, arginine deiminase, ornithine carbamoyltransferase and ribonucleoside hydrolase RihC), although it has not been elucidated if the insertion is genetically encoded. The same authors, in a previous work, revealed the expression of a selenocysteine lyase, involved in the metabolism of SeCys, suggesting once more the ability of the strain to metabolize Se introducing the element into proteins [126] . None of these proteins has been previously described as selenoprotein in other bacteria, opening new perspectives on the study of the "selenoprotein world" in probiotic Gram positive bacteria.
